Martingale Asset Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-760
| Closed | -$51.3K | – | 806 |
|
|
2023
Q2 | $51.3K | Sell |
760
-330
| -30% | -$22.3K | ﹤0.01% | 793 |
|
|
2023
Q1 | $508K | Sell |
1,090
-433
| -28% | -$202K | 0.01% | 612 |
|
|
2022
Q4 | $610K | Sell |
1,523
-87
| -5% | -$34.8K | 0.01% | 583 |
|
|
2022
Q3 | $524K | Sell |
1,610
-51
| -3% | -$16.6K | 0.01% | 611 |
|
|
2022
Q2 | $439K | Buy |
1,661
+187
| +13% | +$49.4K | 0.01% | 667 |
|
|
2022
Q1 | $444K | Sell |
1,474
-320
| -18% | -$96.4K | 0.01% | 665 |
|
|
2021
Q4 | $633K | Sell |
1,794
-124
| -6% | -$43.8K | 0.01% | 592 |
|
|
2021
Q3 | $491K | Buy |
1,918
+1,013
| +112% | +$259K | 0.01% | 676 |
|
|
2021
Q2 | $603K | Buy |
905
+384
| +74% | +$256K | 0.01% | 541 |
|
|
2021
Q1 | $453K | Hold |
521
| – | – | 0.01% | 632 |
|
|
2020
Q4 | $483K | Sell |
521
-228
| -30% | -$211K | 0.01% | 625 |
|
|
2020
Q3 | $770K | Sell |
749
-36
| -5% | -$37K | 0.01% | 707 |
|
|
2020
Q2 | $796K | Sell |
785
-40
| -5% | -$40.6K | 0.01% | 785 |
|
|
2020
Q1 | $717K | Buy |
825
+48
| +6% | +$41.7K | 0.01% | 748 |
|
|
2019
Q4 | $833K | Buy |
777
+308
| +66% | +$330K | 0.01% | 797 |
|
|
2019
Q3 | $434K | Buy |
+469
| New | +$434K | ﹤0.01% | 897 |
|